General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Edwards(MODEST), AstraZeneca Pharmaceuticals(MODEST), Novartis Corporation(MODEST), Boehringer Ingelheim Pharmaceuticals, Inc(MODEST), Bayer Healthcare Pharmaceuticals(MODEST), Novo Nordisk Inc.(MODEST)
